Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01644903 · ClinicalTrials.gov registry record
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
A clinical trial of Hepatitis C and Chronic Kidney Disease, sponsored by Northwestern University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT01644903 is a study of Hepatitis C and Chronic Kidney Disease that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 1,000 participants, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01644903, a study of Hepatitis C and Chronic Kidney Disease, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Conditions Studied
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-04 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01644903
The ClinicalTrials.gov registry entry for NCT01644903 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,881-participant average among 106 other Hepatitis C trials with a reported enrollment target (47% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01644903 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01644903 about?
NCT01644903 is a clinical study titled "Proteogenomic Monitoring and Assessment of Liver Transplant Recipients". This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function prop...
What is the current status of trial NCT01644903?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2010-04. Estimated completion is 2028-12.
What conditions does trial NCT01644903 study?
This clinical trial studies the following conditions: Hepatitis C, Chronic Kidney Disease, Liver Transplant, Acute Rejection.
Who is sponsoring clinical trial NCT01644903?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01644903 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.